Skip to content Synspira
Synspira Mobile Menu Toggle navigation
  • About
    • Who We Are
    • Our Focus
    • Leadership
    • Board
      of Directors
  • Therapeutic Areas
    • Progressive
      Pulmonary Disease
    • Malabsorption
      Syndromes
  • Patient Focus
    • Cystic Fibrosis
    • Other Rare
      Disease Areas
  • Product Development
  • News & Publications
    • Press Releases
    • Publications
      & Abstracts
  • Contact
  • About
    • Who We Are
    • Our Focus
    • Leadership
    • Board
      of Directors
  • Therapeutic Areas
    • Progressive
      Pulmonary Disease
    • Malabsorption
      Syndromes
  • Patient Focus
    • Cystic Fibrosis
    • Other Rare
      Disease Areas
  • Product Development
  • News & Publications
    • Press Releases
    • Publications
      & Abstracts
  • Contact

Publications
& Abstracts

Synspira
  • Press Releases
  • Publications
    & Abstracts
  • August 03, 2018 | In vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus

    View PDF of the Article
  • January 17, 2018 | Novel glycopolymer eradicates antibiotic- and CCCP- induced persister cells in Pseudomonas aeruginosa

    View PDF of the Article
  • June 29, 2017 | Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem

    View PDF of the Article
  • Privacy Policy
  • Terms & Conditions
  • FCOI Policy
  • LinkedIn
  • Twitter

©2023 Synspira Therapeutics Inc.

All Rights Reserved.